Abogen will receive $575 million upfront, with up to $7.2 billion in milestone payments tied to clinical development, approvals and commercial milestones.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.